Judges side with FDA in rejecting stem cell device

March 22, 2013

(AP)—A federal appeals court is siding with the Food and Drug Administration in a case brought by medical device maker Cytori, ruling that the agency was correct to reject fast-track approval for two company devices used to process adult stem cells.

Cytori makes the Celution and StemSource devices which separate from fat tissue using a combination of spinning motions and . The company asked the FDA to approve the devices using a fast-track pathway reserved for devices that are similar to products already on the market. Cytori argued that its devices are similar to devices used to process blood and bone marrow.

A three-judge panel said the FDA was right to reject that argument and to require the company to apply through a more rigorous process.

shares

Related Stories

Recommended for you

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

nanotech_republika_pl
not rated yet Mar 23, 2013
They will move to Mexico.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.